The state of New Mexico urged a judge to hold Walgreens Boots Alliance Inc responsible for fueling the opioid crisis in the state.
Dan Alberstone, a lawyer for New Mexico, told Judge Francis Matthew in the 1st Judicial Circuit of New Mexico in Santa Fe, that the opioid crisis existing in New Mexico was a foreseeable consequence of Walgreens' conduct."
Alberstone accused the company of failing to "maintain effective controls" against the diversion of opioids onto the black market, saying it dispensed suspicious prescriptions without adequate due diligence or documentation.
Steven Derringer, the lawyer arguing for Walgreens, insisted that the opioid crisis was caused by excessive prescriptions and smaller, "mom and pop" pharmacies with lax controls. He added that the state had not offered any evidence that Walgreens dispensed any prescriptions without "legitimate medical purpose."
When the non-jury trial began six weeks ago, it also included claims against Walmart Inc and Kroger Co, but those companies settled with the state last month.


Sanofi, Regeneron Expand Drug Partnership in $8 Billion Deal
Meta Found Liable in New Mexico Facebook Data Privacy Case
Venezuela Nears Deal to Move $4 Billion in Gold to New York Fed
Appeals Court Rejects Trump Third-Country Deportation Policy
Kazakhstan and Tether Explore Tenge Stablecoin and RWA Tokenization
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Intel Reaffirms Role in Elon Musk’s Terafab Chip Project
Trump Opens Tax-Exempt Dyed Diesel Access as Fuel Prices Surge
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
US Supreme Court Revives Trump Administration Voter Citizenship Database
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Dollar Retreats From 18-Month High as Euro Rebounds
GLP-1 Weight-Loss Drug Use Surges Among U.S. Children
World Bank Raises South Asia Growth Forecast to 6.9%
RBI Raises Repo Rate to 5.50% in Hawkish Shift on Inflation Risks 



